RB1 Circulating Tumor DNA in the Blood of Patients with Unilateral Retinoblastoma

RB1 Circulating Tumor DNA in the Blood of Patients with Unilateral Retinoblastoma

Purpose: Circulating tumor DNA (ctDNA) is released by many tumors into the plasma. Its analysis has minimal procedural risk and, in many cancers, has the potential for clinical applications. In retinoblastoma, the clinical correlations of ctDNA in eyes treated without enucleation have not been studi...

Full description

Bibliographic Details
Main Authors: Jasmine H. Francis, MD, Y. Pierre Gobin, MD, A. Rose Brannon, PhD, Christina E. Swartzwelder, RPA-C, Michael F. Berger, PhD, Diana L. Mandelker, MD, PhD, Michael F. Walsh, MD, Ira J. Dunkel, MD, David H. Abramson, MD
Format: Article
Language:English
Published: Elsevier 2021-09-01
Series:Ophthalmology Science
Subjects:
Biomarker
Cell free DNA
Circulating tumor DNA
Intra-arterial chemotherapy
Retinoblastoma
Online Access:http://www.sciencedirect.com/science/article/pii/S2666914521000403

Internet

http://www.sciencedirect.com/science/article/pii/S2666914521000403

Similar Items